Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson’s disease

Highlights• The CBD treatment decreases hyperalgesia and allodynia in experimental parkinsonism. • The inverse agonist of the CB1 receptor prevents the antinociceptive effect of CBD. • FAAH inhibitor or TRPV1 antagonist potentiates the CBD antinociceptive effect. Abstract Medications that improve pain threshold can be useful in the pharmacotherapy of Parkinson’s disease (PD). Pain is a […]

Read More »

Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders

A new application for omega-3 fatty acids has recently emerged, concerning the treatment of several mental disorders. This indication is supported by data of neurobiological research, as highly unsaturated fatty acids (HUFAs) are highly concentrated in neural phospholipids and are important components of the neuronal cell membrane. They modulate the mechanisms of brain cell signaling, […]

Read More »

Higher Plasma LDL-Cholesterol is Associated with Preserved Executive and Fine Motor Functions in Parkinson’s Disease

Plasma low density lipoprotein (LDL) cholesterol has been associated both with risk of Parkinson’s disease (PD) and with age-related changes in cognitive function. This prospective study examined the relationship between baseline plasma LDL-cholesterol and cognitive changes in PD and matched Controls. Fasting plasma LDL-cholesterol levels were obtained at baseline from 64 non-demented PD subjects (62.7 […]

Read More »

Brain fuel metabolism, aging, and Alzheimer’s disease

Lower brain glucose metabolism is present before the onset of clinically measurable cognitive decline in two groups of people at risk of Alzheimer’s disease–carriers of apolipoprotein E4, and in those with a maternal family history of AD. Supported by emerging evidence from in vitro and animal studies, these reports suggest that brain hypometabolism may precede […]

Read More »

Reduced Risk of Dementia in Elderly Tied to Higher Cholesterol Levels

Total cholesterol and cognition associations differ in studies at different outcome ages. Some associations of cholesterol with cognition diminish as outcome age increases. In the oldest-old, some relationships reverse from younger elderly samples. Studies seeking protection should focus on good cognition despite high risk. Some associations of high total cholesterol with dementia risk diminish as […]

Read More »

Canola Oil Linked to Worsened Memory and Learning Ability

In recent years consumption of canola oil has increased due to lower cost compared with olive oil and the perception that it shares its health benefits. However, no data are available on the effect of canola oil intake on Alzheimer’s disease (AD) pathogenesis. Herein, we investigated the effect of chronic daily consumption of canola oil […]

Read More »

Midlife Hypertension and 20-Year Cognitive Change

Hypertension is a treatable potential cause of cognitive decline and dementia, but its greatest influence on cognition may occur in middle age. The objective of the study was to evaluate the association between midlife (48-67 years of age) hypertension and the 20-year change in cognitive performance. The Atherosclerosis Risk in Communities cohort (1990-1992 through 2011-2013) […]

Read More »

The ketogenic diet as a potential treatment and prevention strategy for Alzheimer’s disease

The prevalence of Alzheimer’s disease, a chronic neurodegenerative condition, is increasing as is the need for effective treatments and preventions. The underlying pathology of Alzheimer’s is not yet fully understood, so existing research has focused on understanding the prominent features of the disease. These include amyloid plaques, which accumulate in the brains of those with […]

Read More »

Coffee, Caffeine, and Health Outcomes: An Umbrella Review

To evaluate the associations between coffee and caffeine consumption and various health outcomes, we performed an umbrella review of the evidence from meta-analyses of observational studies and randomized controlled trials (RCTs). Of the 59 unique outcomes examined in the selected 112 meta-analyses of observational studies, coffee was associated with a probable decreased risk of breast, […]

Read More »